VIR Smart Money
Vir Biotechnology, Inc.
1W: +8.1%
1M: +3.6%
3M: +24.8%
YTD: +85.9%
1Y: +91.0%
3Y: +34.6%
5Y: -71.5%
$11.57
+0.53 (+4.80%)
After Hours: $11.32 (-0.25, -2.12%)
Weekly Expected Move ±7.6%
$9
$10
$11
$11
$12
Credit Risk of going bust: lower than 56% of companies Debt: 4.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.07 (down 99.4%), Vir Biotechnology, Inc. would be worth roughly what it owes.
Total debt $93.3M against a stock market value of $1.87B.
Distance to default 5.80 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $46.6M (short-term plus half of long-term), stock volatility 63.0%; Altman Z'' 2.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.07 (down 99.4%), Vir Biotechnology, Inc. would be worth roughly what it owes.
Total debt $93.3M against a stock market value of $1.87B.
Distance to default 5.80 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $46.6M (short-term plus half of long-term), stock volatility 63.0%; Altman Z'' 2.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026283
Institutions Holding
+3 vs prior
80.5%
Ownership
+13.72%
33
New
92
Increased
119
Reduced
43
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | MORE ROBERT J | director | J-J | 8,000 | $— | $0 | Filing |
| 2026-06-09 | Coughlin Timothy | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-06-01 | Sabatini Brent | officer: svp, chief accounting officer | S-Sale | 379 | $9.45 | $4K | Filing |
| 2026-06-01 | Napolitano Janet | director | S-Sale | 3,200 | $9.45 | $30K | Filing |
| 2026-05-27 | BISCHOFBERGER NORBERT W | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-05-27 | Farid Ramy | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-05-27 | Hatfield Jeffrey S. | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-05-27 | MORE ROBERT J | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-05-27 | Napolitano Janet | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-05-27 | Sigal Charles Elliott | director | A-Grant/Award | 8,000 | $— | $0 | Filing |
| 2026-05-01 | SATO VICKI L | director | S-Sale | 22,000 | $10.05 | $221K | Filing |
| 2026-04-29 | De Backer Marianne | officer: president and ceo | J-J | 233,532 | $— | $0 | Filing |
| 2026-04-06 | De Backer Marianne | officer: president and ceo | S-Sale | 72,559 | $9.16 | $664K | Filing |
| 2026-04-01 | SATO VICKI L | director | S-Sale | 22,000 | $9.07 | $200K | Filing |
| 2026-03-20 | O'Byrne Jason | officer: evp & chief financial officer | J-J | 2,500 | $— | $0 | Filing |
| 2026-03-02 | SATO VICKI L | director | S-Sale | 200 | $9.98 | $2K | Filing |
| 2026-03-02 | SATO VICKI L | director | S-Sale | 21,800 | $9.50 | $207K | Filing |
| 2026-02-25 | de Verneuil Vanina | officer: evp, general counsel, corp sec | S-Sale | 13,700 | $9.82 | $135K | Filing |
| 2026-02-25 | Eisner Mark | officer: evp and chief medical officer | S-Sale | 1,889 | $9.82 | $19K | Filing |
| 2026-02-24 | O'Byrne Jason | officer: evp & chief financial officer | S-Sale | 1,634 | $9.53 | $16K | Filing |
| 2026-02-24 | de Verneuil Vanina | officer: evp, general counsel, corp sec | S-Sale | 3,117 | $9.53 | $30K | Filing |
| 2026-02-24 | Sabatini Brent | officer: svp, chief accounting officer | S-Sale | 1,430 | $9.53 | $14K | Filing |
| 2026-02-24 | SATO VICKI L | director | S-Sale | 200 | $10.26 | $2K | Filing |
| 2026-02-24 | SATO VICKI L | director | S-Sale | 42,177 | $9.75 | $411K | Filing |
| 2026-02-24 | De Backer Marianne | officer: chief executive officer | S-Sale | 14,762 | $9.53 | $141K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20,678,283 | $211M | +2,679,954 | 2026-06-30 | Filing |
| ARCH Venture Management, LLC | 12,694,163 | $129M | -222,500 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11,495,215 | $117M | +2,279,638 | 2026-06-30 | Filing |
| SB INVESTMENT ADVISERS (UK) LTD | 10,948,093 | $112M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 9,964,151 | $102M | +2,823,057 | 2026-06-30 | Filing |
| GSK plc | 8,550,954 | $87M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,388,775 | $65M | +1,006,672 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 5,666,821 | $58M | +3,714,587 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,348,366 | $34M | +690,523 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 3,119,421 | $32M | +539,743 | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 2,456,677 | $25M | -288,037 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,365,219 | $24M | -885,008 | 2026-06-30 | Filing |
| FMR LLC | 2,318,294 | $24M | +246,446 | 2026-06-30 | Filing |
| MORGAN STANLEY | 2,211,077 | $23M | -643,128 | 2026-06-30 | Filing |
| Nuveen, LLC | 1,982,942 | $20M | +963,978 | 2026-06-30 | Filing |
| Pictet Asset Management Holding SA | 1,953,316 | $20M | +472,488 | 2026-06-30 | Filing |
| Boxer Capital Management, LLC | 1,866,000 | $19M | — | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 1,432,165 | $15M | +446,730 | 2026-06-30 | Filing |
| Hudson Bay Capital Management LP | 1,364,000 | $14M | -105,510 | 2026-06-30 | Filing |
| GordonMD Global Investments LP | 1,353,552 | $14M | -165,000 | 2026-06-30 | Filing |